Engineering the Future of Precision Medicine
We translate complex, multi-modal patient data into clinically-validated biomarkers and predictive algorithms.
A Data-Driven R&D Engine
Our platform is built on three foundational pillars, creating a powerful "Lab-in-the-loop" system to accelerate discovery.
Proprietary Data Access
We leverage multi-modal patient databases, integrating deep-phenotype EHRs, biochemical panels, and advanced imaging data.
Novel Algorithm Development
Our data science core develops proprietary algorithms to uncover complex biological signatures and predict therapeutic response.
Real-World Validation
Every discovery is rigorously tested to ensure our biomarkers are robust, reliable, and clinically relevant.
Our Clinical-Stage Pipeline
Our platform has yielded two initial products advancing through clinical trials.
T2DM Precision Management
A predictive platform for Type 2 Diabetes that uses novel biomarkers to stratify patients and optimize therapeutic strategies.
In Clinical Trials
Breast Cancer Prognostics
An algorithmic biomarker for early-stage breast cancer to more accurately predict recurrence risk and guide therapy decisions.
In Clinical TrialsKey Publications
Our research is published in leading peer-reviewed journals.
Engineering the Future of Diagnostics
QuantBioMed was founded to bridge the critical gap between raw biological data and actionable clinical insight. As a data-driven R&D engine, we are uniquely positioned with proprietary data sources to power the next generation of precision medicine.
Our Offices
London
10 Regal Walk
Bexleyheath, London
DA6 7BP, United Kingdom
Kolkata
Lakewood Estate
Patuli, Kokata
700084, India
Bangalore
Old Airport Road
Old Town, Bangalore
560017, India